跳至主要内容
临床试验/NCT05438511
NCT05438511招募中不适用

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

Memorial Sloan Kettering Cancer Center2 个研究点 分布在 2 个国家目标入组 85 人开始时间: 2023年4月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
85
试验地点
2
主要终点
Identify barriers for breast cancer diagnosis in Tanzania.

研究概览

简要总结

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Participant Inclusion Criteria for interviews and focus group discussions (Aims 1 and 2):
  • •Breast cancer survivor, patient advocate or key healthcare personnel
  • •Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with:
  • •>12 months of employment at the affiliated institution
  • •Administrative or clinical involvement in the delivery of breast cancer care services.
  • •Age 18 years and above
  • •Permanent residents or citizens of Tanzania
  • •Participant and/or LAR willing and able to consent
  • •Fluent in Swahili and/or English by self-report
  • •Participant

排除标准

  • •Key stakeholder not residing at their particular institutions during data collection will be excluded.
  • •Eligibility criteria for Chart Reviews (Aim 1)
  • •Inclusion Criteria for chart review:
  • •Age 18 years and above
  • •Permanent residents or citizens of Tanzania
  • •Received breast cancer diagnosis
  • •Exclusion Criteria for chart review:
  • •Participants less than 18 years of age

研究组 & 干预措施

Participants of focus groups

Breast cancer survivor, patient advocate or key healthcare personnel including hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons

干预措施: Focus group (Behavioral)

Participants of focus groups

Breast cancer survivor, patient advocate or key healthcare personnel including hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons

干预措施: Organizational Readiness for Implementing Change (Behavioral)

结局指标

主要结局

Identify barriers for breast cancer diagnosis in Tanzania.

时间窗: 1 year

Depending on results of this initial evaluation, either additional data will be collected, or if successful, will use the data to begin identifying context-specific implementation strategies using the 'Implementation Mapping' framework1 . In a future protocol, these data will then be used to develop a strategy for an intervention that addresses urgent evidence-to-practice gaps in breast cancer diagnosis in Tanzania, and has the potential to help patients with breast cancer in sub-Saharan Africa (SSA) in the future. The collection of this key information will assist us and our collaborators to generate background data that can be used to develop and/or complement future clinical trials.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验